Rash Due to Epidermal Growth Factor Receptor Inhibitors
3 clinical trials · Condition
◉ Watch Rash Due to Epidermal Growth Factor Receptor Inhibitors
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based Regimens (NCT07469488) | Shanghai Pulmonary Hospital, Shanghai, China | 2026-04-30 |
| Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients (NCT02239731) | Vyne Therapeutics Inc. | 2014-10-01 |
| A Study to Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI (NCT01763307) | Hadassah Medical Organization | 2013-01-01 |
Track Rash Due to Epidermal Growth Factor Receptor Inhibitors automatically
Every clearance here is in the API, with alerts when new ones post.